As the novel coronavirus spread across the globe in early 2020, hospitals worldwide scaled back medical procedures, including life-saving heart surgery, to deal with the emerging threat of COVID-19.
The Cardiovascular Research Foundation (CRF) has announced that Transcatheter Cardiovascular Therapeutics (TCT) 2020 will now take place as a virtual event called TCT Connect. The event will take place online October 14-18, 2020 and feature live case-based transmissions from around the globe, late-breaking clinical trials and science, virtual training, and countless opportunities to learn and engage with the brightest minds in interventional cardiovascular medicine.
PCR and CRF are pleased to announce the creation of virtual Partners in Learning sessions that will be broadcast during the PCR e-Course (June 25-27, 2020) and CRF’s TVT Connect meeting (June 18-28, 2020). The sessions, which will cover coronary artery disease in TAVI patients and TAVI in low risk patients, are part of a collaborative educational series from the two groups.
Higher spirituality among stroke survivors was strongly linked to better quality of life for them and their caregivers who may also feel depressed, according to new research published today in Circulation: Cardiovascular Quality and Outcomes, an American Heart Association journal. May is American Stroke Month.
An interdisciplinary research team establishes a new technological pipeline to build a 3D map of the neurons in the heart, revealing foundational insight into their role in heart function and cardiac disease
Atrial fibrillation ranks among the most common heart conditions, and episodes are difficult to predict. Researchers have proposed a way to define cardiac state and have studied the dynamics before the cardiac rhythm changes from normal sinus to AF rhythm and vice versa. The work, appearing in Chaos and based on critical transition theory, looks to provide an early warning for those with paroxysmal atrial fibrillation with potential implications for future wearable devices.
The Cardiovascular Research Foundation (CRF) has announced that TVT Connect, the Structural Heart Summit, will take place online June 18-28, 2020. TVT Connect features expertly developed series, late-breaking clinical science, challenging cases, industry-sponsored sessions, and connection to a community of thought leaders from across the globe.
Transforming how common health conditions are diagnosed using point-of-care and wearable bio diagnostic devices is the goal of a new $2.2 million University of South Australia project.
Strokes are the fifth most common cause of death in the United States and a leading cause of disability among survivors. Fortunately, most strokes — more than 80% — are preventable by managing risk factors.
Many patients with heart disease face limited treatment options. Fortunately, stem cell biology has enabled researchers to produce large numbers of cardiomyocytes, which may be used in advanced drug screens and cell-based therapies. However, current image analysis techniques don’t allow researchers to analyze heterogeneous, multidirectional, striated myofibrils typical of immature cells. In the Journal of Applied Physics, researchers showcase an algorithm that combines gradient methods with fast Fourier transforms to quantify myofibril structures in heart cells with considerable accuracy.
Johns Hopkins researchers recently received a $195,000 Rapid Response Research grant from the National Science Foundation to, using machine learning, identify which COVID-19 patients are at risk of adverse cardiac events such as heart failure, sustained abnormal heartbeats, heart attacks, cardiogenic shock and death.
Is personalized medicine cost-effective? Researchers have answered that question for one medical treatment, genotype-guided antiplatelet therapy for acute coronary syndrome patients with PCI. Their study uses pharmacogenomics and economic analysis of real-world clinical data.
Oxidative stress can be pathological. Now researchers report that the other end of the redox spectrum, reductive stress, is also pathological. Reductive stress causes pathological heart enlargement and diastolic dysfunction in a mouse model.
During the COVID-19 pandemic, Johns Hopkins Medicine Media Relations is focused on disseminating current, accurate and useful information to the public via the media. As part of that effort, we are distributing our “COVID-19 Tip Sheet: Story Ideas from Johns Hopkins” every Tuesday throughout the duration of the outbreak.
An international expert on pediatric infectious diseases, is concerned that people will attribute to Kawasaki disease the mysterious syndrome that was first reported in Europe and seen most recently in New York City children with COVID-19. However, the more likely explanation of this new entity is toxic shock syndrome, says Moshe Arditi, MD.
By combining the fine-grained detail available from animal studies with the statistical power of genetic studies involving hundreds of thousands of human genomes, researchers have discovered a new gene involved in regulating the body’s cholesterol.
Research published today indicates that screenings that incorporate an ECG are more effective at detecting cardiac conditions that put athletes at risk, and more efficient in terms of cost-per-diagnosis of at-risk players, than screenings involving only a physical exam and patient history.
Intensive blood pressure control may reduce the risk of atrial fibrillation (AFib), an irregular heartbeat that can lead to serious complications such as stroke, heart failure and heart attacks, according to scientists at Wake Forest School of Medicine.
ما يزال ثمة الكثير من المجهول بشأن كوفيد-19، لكن العديد من الدراسات أشارت بالفعل إلى أن الأشخاص المصابين بالمرض القلبي الوعائي هم أكثر عرضة لخطر كوفيد-19. كانت هناك أيضًا تقارير عن ارتفاع مقطع ST، وهي إشارة إلى مرض الشريان التاجي الانسدادي، وذلك لدى المرضى المصابين بكوفيد-19 الذين لم تظهر عليهم علامات المرض بعد تصوير الأوعية التاجية المتوغل.
Aunque todavía quedan muchas incógnitas acerca de la COVID-19, varios estudios indican que las personas con enfermedades cardiovasculares corren más riesgo de contraerla. Además, se ha informado sobre la presencia de un signo de la cardiopatía coronaria obstructiva, la elevación en el segmento ST (STE, por sus siglas en inglés), en pacientes con COVID-19 que después de una angiografía coronaria no mostraron ninguna señal de la enfermedad.
Ainda não se sabe muito sobre a COVID-19, mas muitos estudos já indicaram que pessoas com doenças cardiovasculares têm maior risco para a COVID-19. Houve também relatos de elevação do segmento ST, um sinal de doença arterial coronariana obstrutiva, em pacientes com COVID-19 que após angiografia coronária invasiva não mostraram sinal da doença.
The rate of heart attacks, strokes and other cardiovascular complications has improved among people with diabetes over the past 20 years, narrowing the gap in cardiovascular mortality rates between individuals with and without diabetes, according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.
New guidance from the American Academy of Neurology (AAN) concludes that closure of a common heart defect called a patent foramen ovale (PFO) may be recommended for some people who have had a stroke. The updated practice advisory is published in the April 29, 2020, online issue of Neurology®, the medical journal of the American Academy of Neurology.
People with certain heart diseases may be more susceptible to worse outcomes with COVID-19, but the reason why has remained unknown. New research from Mayo Clinic indicates that in patients with one specific type of heart disease ― obstructive hypertrophic cardiomyopathy (HCM) ― the heart increases production of the ACE2 RNA transcript and the translated ACE2 protein.
New research finds that nicotine-filled e-cigarettes cause increases in heart rate and blood pressure in young people, health issues that remain even after a vaping session.
A new study helps explain why people with post-traumatic stress disorder (PTSD) face a higher risk of heart disease at an earlier age than people without PTSD.
Many hospitals across the country have noticed an increase of people ignoring life-threatening symptoms. They are choosing to stay home, instead of seeking care at an emergency department. When they do arrive at the hospital, the patient has lost critical time to receive life-saving treatments.
Quienes padecen enfermedades cardíacas y otras afecciones corren más riesgo de enfermar gravemente si llegan a desarrollar la COVID-19. Por ello, los pacientes cardíacos posiblemente se pregunten si están haciendo lo correcto para su salud en este momento, cuando hay pocos estudios respecto a esta nueva enfermedad viral.
المصابون بأمراض القلب والحالات الصحية الكامنة الأخرى أكثر عرضة للمرض الخطير إذا أصيبوا بفيروس كورونا المستجد (كوفيد-19). قد يتساءل مرضى القلب عما إذا كانوا يفعلون ما يجب من أجل صحتهم، في وقت لا يتوفر فيه عن هذا المرض الفيروسي الجديد إلا القليل من الأبحاث.
Pessoas com doença cardíaca e outros problemas de saúde subjacentes correm o risco de ficarem gravemente doentes se contraírem a COVID-19. Pacientes cardíacos podem questionar se estão fazendo as coisas certas para sua saúde em um momento em que há poucas pesquisas disponíveis a respeito dessa nova doença viral.
اكتشف باحثو مايو كلينك (Mayo Clinic) آليات شفاء بتنشيط الخلايا الجذعية بعد نوبة قلبية حيث أعادت الخلايا الجذعية عضلة القلب إلى حالتها قبل النوبة القلبية، ما قدم مخططًا لكيفية عمل الخلايا الجذعية.
Pesquisadores da Mayo Clinic descobriram mecanismos de cura ativados por células-tronco após um ataque cardíaco. As células-tronco restauraram o músculo cardíaco devolvendo-o ao seu estado anterior ao ataque cardíaco, fornecendo um esquema sobre como as células-tronco podem funcionar.
Sam Torbati, MD, has a message for anyone experiencing symptoms of heart disease in the midst of the COVID-19 pandemic:"Either call your doctor or come to the Emergency Department. Don't take chances with heart disease." Torbati is worried that patients might fear getting medical treatment would expose them to COVID-19.
UT Southwestern Medical Center scientists have discovered a protein that works with others during development to put the brakes on cell division in the heart, they report today in Nature.
Doctors and researchers are just beginning to document and understand the effects of heart disease in complicating and endangering recovery from the COVID-19 virus, as well as the potential impact of COVID-19 on the heart. In a new Loyola Medicine video, “Heart Disease and COVID-19,” cardiologist Asim Babar, MD, recommends that individuals with heart disease take especially good care of their health and heart during this pandemic.
In the first study of its kind, Johns Hopkins researchers provide evidence that an alternative imaging technique could someday replace current methods that require potentially harmful radiation.
During the COVID-19 pandemic, Johns Hopkins Medicine Media Relations is focused on disseminating current, accurate and useful information to the public via the media. As part of that effort, we are distributing our “COVID-19 Tip Sheet: Story Ideas from Johns Hopkins” every Tuesday throughout the duration of the outbreak.